Found: 27
Select item for more details and to access through your institution.
Bacteria in cancer therapy: A new generation of weapons.
- Published in:
- Cancer Medicine, 2022, v. 11, n. 23, p. 4457, doi. 10.1002/cam4.4799
- By:
- Publication type:
- Article
Identifying tumor antigens and immuno‐subtyping in colon adenocarcinoma to facilitate the development of mRNA vaccine.
- Published in:
- Cancer Medicine, 2022, v. 11, n. 23, p. 4656, doi. 10.1002/cam4.4846
- By:
- Publication type:
- Article
Construction and validation of a prognostic model based on 11 lymph node metastasis‐related genes for overall survival in endometrial cancer.
- Published in:
- Cancer Medicine, 2022, v. 11, n. 23, p. 4641, doi. 10.1002/cam4.4844
- By:
- Publication type:
- Article
Light‐intensity and moderate‐to‐vigorous intensity physical activity among older adult breast cancer survivors with obesity: A narrative review.
- Published in:
- Cancer Medicine, 2022, v. 11, n. 23, p. 4602, doi. 10.1002/cam4.4841
- By:
- Publication type:
- Article
Simple IHC reveals complex MMR alternations than PCR assays: Validation by LCM and next‐generation sequencing.
- Published in:
- Cancer Medicine, 2022, v. 11, n. 23, p. 4479, doi. 10.1002/cam4.4832
- By:
- Publication type:
- Article
Locoregional recurrence after nephrectomy for localized renal cell carcinoma: Feasibility and outcomes of different treatment modalities.
- Published in:
- Cancer Medicine, 2022, v. 11, n. 23, p. 4430, doi. 10.1002/cam4.4790
- By:
- Publication type:
- Article
Oncolytic adenovirus H101 ameliorate the efficacy of anti‐PD‐1 monotherapy in colorectal cancer.
- Published in:
- Cancer Medicine, 2022, v. 11, n. 23, p. 4575, doi. 10.1002/cam4.4845
- By:
- Publication type:
- Article
Estimates of incidence, prevalence, mortality, and disability‐adjusted life years of lung cancer in Iran, 1990–2019: A systematic analysis from the global burden of disease study 2019.
- Published in:
- Cancer Medicine, 2022, v. 11, n. 23, p. 4624, doi. 10.1002/cam4.4792
- By:
- Publication type:
- Article
SPP1 promotes radiation resistance through JAK2/STAT3 pathway in esophageal carcinoma.
- Published in:
- Cancer Medicine, 2022, v. 11, n. 23, p. 4526, doi. 10.1002/cam4.4840
- By:
- Publication type:
- Article
Clinicopathological characteristics and prognosis of microinvasive breast cancer: A population‐based analysis.
- Published in:
- Cancer Medicine, 2022, v. 11, n. 23, p. 4501, doi. 10.1002/cam4.4839
- By:
- Publication type:
- Article
A novel DNA methylation‐driver gene signature for long‐term survival prediction of hepatitis‐positive hepatocellular carcinoma patients.
- Published in:
- Cancer Medicine, 2022, v. 11, n. 23, p. 4721, doi. 10.1002/cam4.4838
- By:
- Publication type:
- Article
Performance of subjective global nutritional assessment in predicting clinical outcomes: Data from the Brazilian survey of pediatric oncology nutrition.
- Published in:
- Cancer Medicine, 2022, v. 11, n. 23, p. 4612, doi. 10.1002/cam4.4837
- By:
- Publication type:
- Article
A novel prognostic model for papillary thyroid cancer based on epithelial–mesenchymal transition‐related genes.
- Published in:
- Cancer Medicine, 2022, v. 11, n. 23, p. 4703, doi. 10.1002/cam4.4836
- By:
- Publication type:
- Article
DDX24 promotes metastasis by regulating RPL5 in non‐small cell lung cancer.
- Published in:
- Cancer Medicine, 2022, v. 11, n. 23, p. 4513, doi. 10.1002/cam4.4835
- By:
- Publication type:
- Article
Alectinib versus crizotinib in ALK‐positive advanced non‐small cell lung cancer and comparison of next‐generation TKIs after crizotinib failure: Real‐world evidence.
- Published in:
- Cancer Medicine, 2022, v. 11, n. 23, p. 4491, doi. 10.1002/cam4.4834
- By:
- Publication type:
- Article
Childhood cancer survivorship in China: An overview of the past two decades.
- Published in:
- Cancer Medicine, 2022, v. 11, n. 23, p. 4588, doi. 10.1002/cam4.4831
- By:
- Publication type:
- Article
Prediction of lung cancer risk in Chinese population with genetic‐environment factor using extreme gradient boosting.
- Published in:
- Cancer Medicine, 2022, v. 11, n. 23, p. 4469, doi. 10.1002/cam4.4800
- By:
- Publication type:
- Article
Demographic differences among patients treated with chimeric antigen receptor T‐cell therapy in the United States.
- Published in:
- Cancer Medicine, 2022, v. 11, n. 23, p. 4440, doi. 10.1002/cam4.4797
- By:
- Publication type:
- Article
Cost‐effectiveness of osimertinib versus placebo in resected EGFR‐mutated non‐small cell lung cancer in China.
- Published in:
- Cancer Medicine, 2022, v. 11, n. 23, p. 4449, doi. 10.1002/cam4.4798
- By:
- Publication type:
- Article
Association of anticoagulant use with clinical outcomes from crizotinib in ALK‐ and ROS1‐rearranged advanced non‐small cell lung cancers: A retrospective analysis of PROFILE 1001.
- Published in:
- Cancer Medicine, 2022, v. 11, n. 23, p. 4422, doi. 10.1002/cam4.4789
- By:
- Publication type:
- Article
Long noncoding RNA GK‐IT1 promotes esophageal squamous cell carcinoma by regulating MAPK1 phosphorylation.
- Published in:
- Cancer Medicine, 2022, v. 11, n. 23, p. 4555, doi. 10.1002/cam4.4795
- By:
- Publication type:
- Article
KBTBD7 promotes non‐small cell lung carcinoma progression by enhancing ubiquitin‐dependent degradation of PTEN.
- Published in:
- Cancer Medicine, 2022, v. 11, n. 23, p. 4544, doi. 10.1002/cam4.4794
- By:
- Publication type:
- Article
DIAPH3 is a prognostic biomarker and inhibit colorectal cancer progression through maintaining EGFR degradation.
- Published in:
- Cancer Medicine, 2022, v. 11, n. 23, p. 4688, doi. 10.1002/cam4.4793
- By:
- Publication type:
- Article
Development of a prediction model for radiotherapy response among patients with head and neck squamous cell carcinoma based on the tumor immune microenvironment and hypoxia signature.
- Published in:
- Cancer Medicine, 2022, v. 11, n. 23, p. 4673, doi. 10.1002/cam4.4791
- By:
- Publication type:
- Article
Neoadjuvant treatment of sintilimab plus hypofractionated radiotherapy for MSI‐H/dMMR rectal cancer: A prospective, multicenter, phase Ib study.
- Published in:
- Cancer Medicine, 2022, v. 11, n. 23, p. 4405, doi. 10.1002/cam4.4720
- By:
- Publication type:
- Article
Integration of bioinformatics analysis and experimental validation identifies plasma exosomal miR‐103b/877‐5p/29c‐5p as diagnostic biomarkers for early lung adenocarcinoma.
- Published in:
- Cancer Medicine, 2022, v. 11, n. 23, p. 4411, doi. 10.1002/cam4.4788
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Cancer Medicine, 2022, v. 11, n. 23, p. 4399, doi. 10.1002/cam4.4010
- Publication type:
- Article